The rationale to institute primary prevention of vascular damage in patients with DM is compelling to reduce morbidity/mortality. Type 1 or 2 DM are at high risk for CVD: coronary artery disease, stroke, peripheral ar terial disease, cardiomyopathy and congestive heart failure. Therefore, it becomes imperative that physicians who take care of clinically diabetic patients or nondiabetics with genetic evidence of diabetes in the family history should search for evidence of impaired glucose tolerance, hyperinsulinemia and lipidemia. Treating a patient with impaired glucose tolerance and overt DM must be a "shared responsibility‰ among specialists of vascular beds involved.
INTRODUCTION
In 1999 the American Diabetes Association, the National Heart, Lung and Blood Institute, the Juvenile Diabetes Foundation Internaitonal, the National Institute of Diabetes and Digestive and Kidney Diseases and the American Heart Association issued a Joint Editorial Statement inditing diabetes mellitus (DM) as a major risk factor for cardiovascular disease (CVD). 1 In the last 3 decades of the 20th century several epidemiology studies have confirmed excess morbidity and mortality due to CVD (Table  I) in patients with DM. [2] [3] [4] [5] [6] [7] [8] [9] [10] All these studies suggest strongly DM as a major risk factor for CVD. In addition, other risk factors for CVD 11 are frequently associated with DM (Table II) .
Recent survey among physicians conducted by the "make the link‰ project of the American College of Cardiology and the American Diabetes Association linking DM with coronary artery disease and stroke found DM as the highest risk factor for CVD, higher than traditional risk factors of smoking, hypertension, hypercholesterolemia or obesity. 12 Fur ther, DM is associated with more extensive atherosclerosis affecting blood vessels in the eyes, brain, heart, kidneys and peripheral arteries in the neck, aorta and lower extremeities. These vascular changes appear several years before overt DM is manifest. 12 Indeed more than just another risk factor for CVD, DM can be conceptualized and correctly called CVD. This review will describe the vascular changes in DM, the mechanisms connecting DM to vascular disease and guidelines for primary prevention of cardiovascular complications in the context that DM is CVD. Figure 1 ). Type 2 DM is most common in adult life. The metabolic cause has been identified as due to the combination of impaired insulin-mediated glucose disposal (insulin resistance) and defective insulin secretion by pancreatic B cells.
14 Insulin resistance precedes onset of DM and often accompanied by hypertension, dyslipidemia, prothrombotic state, impaired fasting glucose (IFG) or impaired glucose tolerance (IGT). This cluster of risk factors is called the metabolic syndrome that antedates the emergence of type 2 DM by many years. 16 Vascular changes in diabetes mellitus
Diabetic retina
There is an initial dilatation of retinal veins. This is followed by loss of endothelial cells and pericytes of capillaries leading to a cellular capillaries and microaneurysms. There is increased vascular permeability allowing the production of hard yellowish exudates, arteriolar occlusions and soft (cotton wool) exudates. Retinitis proliferans is characterized by progressive neovascularization and glial formation with normalization of blood flow.
According to McMillan
17 diabetic microangiopathy star ts with altered local blood flow with dilatation of the small veins, periodic arteriolar vasoconstriction, sclerosis of ar terioles, veins and capillaries resulting in progressive microcirculatory decompensation (Table V) .
Diabetic kidney
Ar teriolosclerosis begins in the af ferent glomerular arteriole and followed by diffuse g l o m e r u l o s c l e r o s i s . T h e l a t t e r l e a d s t o hypertension. Diffuse glomerulosclerosis may be accompanied with nodular glomerulosclerosis producing renal insufficiency. Renin production is depressed but sensitivity to angiotensin II is increased. The glomerular basement membrane thickens and glomerular filtration rate is increased. The evolution of diabetic nephropathy was described by Mogensen 18 in 5 stages in 1987 (Table VI) .
Diabetic peripheral nerve
With onset of diabetic autonomic dysfunction depressed motor conduction velocity becomes manifest. There is segmental demyelination due to Schwann cell deterioration. Symmetric sensory polyneuropathy with loss of deep tendon reflexes is common in long-term DM.
Diabetic extremity
Atherosclerosis obliterans of arteries in one or both lower extremities produce ischemic changes leading to ulceration, gangrene and diabetic foot.
5. Diabetic skin C u t a n e o u s m a n i f e s t a t i o n s o f d i a b e t i c microangiopathy are usually associated with retinopathy, neuropathy and nephropathy. The classic skin lesions are the asymptomatic atrophic brown areas in the leg called necrobiosis lipoidica diabeticorum seen in long-term DM.
6. Diabetic heart and strokes Coronary artery disease affects large and small coronary arteries. Painless myocardial infarction and angina with normal coronary angiogram are not uncommon in diabetic patients. Type 2 DM have more diffuse coronary artherosclerosis and greater prevalence of stenosis of any grade by angiographic study. 19 Necropsy study of coronary arteries in type 2 DM by Waller and co-workers 20 showed identical number of significant obstructive atherosclerotic plaques in the 3 epicardial coronaries in patients with DM without clinical coronary artery disease, DM with coronary artery disease and control subjects with coronary artery disease without DM (Table VII) .
Atherosclerotic carotid and vertebral arterial systems and cerebral vessels may lead to thrombotic strokes. Microaneurysms in the basal ganglia and subcortical region called CharcotBouchard aneur ysms cause hemor rhagic stroke. 21 H y p e r t e n s i o n a n d D M f r e q u e n t l y o c c u r simultaneously leading to excess morbidity and mortality for cardiovascular events and renal disease (Table VIII) . They share the same metabolic features of impaired glucose tolerance and insulin resistance. Likewise the development of complications is related to duration and/or severity of each condition. 22 
Diabetic cardiomyopathy
This is characterized by diffuse areas of fibrosis and hypertrophy. The arteriolar walls present positive periodic acid Schiff (PAS) material. Diabetic cardiomyopathy was first described by Rubler in 1972 23 associated with duration of DM of 5 years or more and nephropathy. 
Mechanisms of cardiovascular damage
Proposed mechanisms linking DM to CVD are uniformly targeted to produce endothelial damage and dysfunction. Three principal substances have been identified to play major roles in producing endothelial dysfunction. They are: heparin sulfate (HS), 24 glucose, [25] [26] [27] [28] and insulin. [29] [30] [31] [32] Loss of HS, glucose scavenging of nitric oxide (NO) and insulin resistance impair endothelial function separately or in concert.
The normal vascular endothelium acts as autocrine and paracrine organ releasing substances that regulates vascular tone, thrombosis and fibrinolysis, permeability and smooth muscle growth as well as extracellular matric composition. Endothelial cell function is finely orchestrated by the integrity of the L-arginine-eNOS-NO system. [28] [29] [30] [31] [32] [33] Hence, normal production and/or availability of NO is essential in regulating various substances generated and released by the endothelial cell through its autocrine and paracrine functions. Damage of vascular endothelium from inappropriate sulphation of heparin sulfate and loss of anionic sites or increased synthesis and secretion of PAI-1 by glucose and insulin stimulation lead to impaired NO production and/or availability.
The writing group II tasked to formulate the executive summary of the American Heart Association sponsored Conference on Prevention VI: Diabetes and Cardiovascular Disease on January 18 to 20, 2001 in Orlando, Florida defined 5 mechanisms relating to pathogenesis of atherosclerosis in DM. 34 They are: 1) metabolic factor arising from insulin deficiency and insulin resistance producing a state of chronic hyperglycemia; 2) excessive oxidation/glucoxidation due to spontaneous nonenzymatic reaction between glucose, lipids and proteins producing advanced glycosylation end products (AGE); 3) endothelial dysfunction is associated with hyperglycemia, dyslipidemia, insulin resistance, hypertension and atherosclerosis (Table VIII) ; 4) inflammation is increased in DM due to excess adipose tissue which is an important source of interleukin-6 Cytokines generate growth factors that stimulate proliferation and migration of vascular smooth muscle cells and induce platelet aggregation; 5) prothrombotic state of DM perpetuating imbalance between prothrombotic mechanisms and antifibrinolytic processes.
In the 1988 Claude Bernard Lecture, Deckert proposed the Steno hypothesis. 24 This hypothesis states that albuminuria and vascular changes are due to genetic polymorphism of N-deacetylase causing inappropriate sulphation of HS. Abnormal sulphation of HS leads to loss of anionic charge in extracellular matric and endothelial membranes and endothelial cell dysfunction. HS is the main glycosaminoglycan of basement membranes of glomer uli, mesangial and endothelial plasma membranes. Tables IX and X describe the properties of HS and the putative mechanism of widespread damage in DM respectively. 24 Abnormal sulphation of HS due to genetic polymorphism of N-deacetylase in combination with environmental factor like poor diabetic control leads to angiopathy (Figure 2 ).
The glucose connection leading to endothelial cell damage is related to the continuous and graded relation across the range of nondiabetic glucose values, independent of traditional and non-traditional risk factors for CVD. 25 Blood glucose scavenging of NO from the endothelium produces cellular effects in endothelial cell, pancreatic B cells, macrophages, nervous tissue and skeletal muscle (Table II) . 26 Vascular effects of hyperglycemia are reversed by L-arginine. 28 Hyperglycemia from poor diabetic control reduces bioavailability of NO through the production of AGE (Table XII) and reactive oxygen species (ROS) ( Table XIII) . It is suggested that the common mechanism of cardiovascular risk factors is oxidative stress. Oxidative stress is a necessary consequence of organisms living in air since 1-5% of inhaled oxygen become ROS. 35   Table IX . Properties of Heparin Sulfate 24 1. Heparan sulfate is the main glycosaminoglycan of basement membranes of glomeruli, mesangial and endothelial plasma membranes. 2. Heparan sulfate after sulphation by N-deacetylase is incorporated in plasma and basement membranes of extracellular matrix and maintains the integrity of the collagen network providing anionic charge. 3. Heparan sulfate inhibits smooth muscle cell growth. 4 . H e p a r a n s u l f a t e i n e n d o t h e l i a l m e m b r a n e s i s antithrombogenic. 5. Heparan sulfate inhibits mesangial cell growth. 1. Hyperglycemia enhances glucose autoxidation and changes in ROS-producing enzymes. 2. ROS stimulates glucose-induced activation of protein-kinase C (PKC) isoforms. 3. ROS activates formation of advanced glycation end products (AGE). 4. ROS stimulates glucose flux and NF-ß activation in endothelial cells.
The acute and chronic stages of endothelial cell dysfunction in a diabetic patient are trigged by hyperglycemia. 25 The presence of AGE perpetuates the impairment of endothelial function through the induction of PAI-1 gene. 26, 27 Insulin stimulates the release of endothelin (ET) and NO (Table XIV) . Imbalance of ET and NO may be involved in the pathophysiology of hypertension and atherosclerosis in insulin resistant state with endothelial dysfunction. [29] [30] [31] Hyperinsulinemia accompanying insulin resistance increases endothelial ET production and release. [30] [31] Insulin resistance is present in patients with impaired glucose tolerance and type 2 DM and hyperinsulinemia precedes type 2 DM. In insulin sensitive state, insulin maintains balance of ET and NO. However, in insulin resistance and hyperinsulinemia there is an imbalance between insulin action on ET and NO producing increased vascular tone and endothelial dysfunction. Insulin resistance and atherosclerosis exist long before clinical disease reveals itself-sharing common histor y. [36] [37] [38] [39] [40] The "common soil‰ hypothesis of Jarrett 36 of DM and atherosclerosis states that these 2 conditions share the same genetic and environmental roots (Table XV) .
CVD is as common in newly diagnosed DM as in DM of long duration and patients with IGT have the same rate of CVD as those with overt DM. 37, 38 Insulin resistance appears to be a multisystem disorder (Table XVI) involving genetics, obesity, physical inactivity, aging and metabolic factors like atherogenesis, dyslipidemia, hypertension, glucose intolerance and prothrombotic state. 41 
Primary Prevention of Cardiovascular Disease in Diabetics
In DM vascular complications are only partially prevented by tight glycemic control. Diabetics have greater CVD morbidity and mortality. 3, 4, 14 41 Type 2 DM patients without prior myocardial infarction are at the same risk of coronary events as nondiabetic patients with prior myocardial infarction. 42, 43 A guide to primary prevention of CVD in patients with diabetes in 1999 was recommended by Grundy et al 14 for control of risk factors with corresponding goals for optimal results. These include: complete abstinence from smoking, blood pressure and glucose control, use of antiplatelet agents, increase in physical activity and weight control. Insulin stimulates production of NO and endothelin. Insulin resistance is present in type 2 DM, obesity and essential hypertension with endothelial dysfunction. Endothelial dysfunction is manifested as diminished blood flow response to cholinergic agonists and insulin Concurrent improvement in endothelial function and insulin sensitivity with exercise, metformin and troglitazone. 
36-40
Insulin resistance and atherosclerosis exist long before the clinical disease reveals itself; they share common history. "Common Soil‰ hypothesis: DM and atherosclerotic CVD share the same genetic and environmental roots. Cardiovascular complications are as common in newly diagnosed DM as in DM of long duration. Patient with impaired glucose tolerance have the same rate of CVD as those with DM. 
CONCLUSION
The intimately incriminating connection between DM and CVD is compelling. The vascular manifestations of DM affect more vascular beds than any other disease. None of the presently known risk factors inflicts more morbidity and mortality in the cardiovascular system than DM. Indeed, DM is not only a major risk factor for CVD but in reality DM is CVD that destroys the vascular beds of several target organs.
The putative mechanisms for the generalized vascular lesions are through heparan sulfate loss, glucose scavenging and insulin resistance separately or jointly producing endothelial dysfunction. Without physical denudation of the endothelium these 3 mechanisms per se can effect widespread endothelial dysfunction. In addition these mechanisms are usually associated with other factors like hemostatic alterations, dyslipidemia and permeability abnormalities.
To d a y n o t m a n y i n t e r n i s t s , d i a b e t o l o g i s t s , nephrologists, neurologists and cardiologists think of DM as a classic model of cardiovascular pathology. DM begins to damage the cardiovascular system even before it is diagnosed, silently building atherosclerotic lesions and aneurysms (micro and macroaneurysms) in coronary arteries and other vessels. Importantly DM causes abnormal lipid levels and impairs vascular homostasis. Patients with impaired glucose tolerance Angiotensin converting enzyme inhibitor (ACEI) has been advocated by Munzel and Keaney 44 as a "magic bullet‰ against oxidative stress since it targets oxidative stress at its source by inhibiting nicotinamide adenine dinucleotide (NADH) phosphate (NAD(P)H) oxidase. By inhibiting NAD(P)H, production of reactive oxygen species (superoxide anion, hydrogen 
